Table 3.
Distribution of mycobacterial, bacterial and other invasive infectious diseases among HIV-positive adults newly hospitalized from April to September 2010, IeDEA West Africa Collaboration
| Classification, N (%)a | Diagnosis, N | |||||||
|---|---|---|---|---|---|---|---|---|
| N (%)a | AIDS | WHO stage 4 | WHO stage 3 | Presumptive | Definitive | Suspected IRIS, N | Suspected Adverse effect, N | |
| Total number of patients | 824 (100) | 445 (100) | 388 (100) | 232 (100) | 45 | 45 | ||
| Mycobacterial diseases | ||||||||
| Tuberculosis | 242 (29.4) | 242 (54.0) | 151 (38.6) | 91 (39.1) | 167 | 75 | 21 | |
| Atypical mycobacteriaeb | 5 (0.6) | 5 (1.1) | 5 (1.3) | 5 | – | 5 | ||
| Bacterial/ invasive infectious diseases | ||||||||
| Infectious diarrhoeac | 69 (8.4) | 68 | 1 | 1 | ||||
| E. coli enteritis | 11 (1.3) | 11 (4.7) | – | 11 | ||||
| Salmonella non-typhi | 8 (1.0) | 3 (0.7) | 3 (0.8) | 4 (1.7) | 1 | 7 | ||
| Shigellosis diarrhoea | 1 (0.1) | 1 (0.4) | – | 1 | ||||
| Pneumonia | 124 (15.0) | 8 (1.8) | 8 (2.0) | 116 (50.0) | 111 | 13 | ||
| Lung abscess | 2 (0.2) | – | 2 | |||||
| Bacterial pleurisy | 4 (0.5) | 4 (1.7) | 1 | 3 | ||||
| Endocarditis | 2 (0.2) | 2 (0.9) | 1 | 1 | ||||
| Meningitis, meningo-encephalitis | 37 (4.5) | 35 (15.1) | 29 | 8 | 1 | |||
| Pyelonephritis | 11 (1.3) | 11 (4.7) | 7 | 4 | ||||
| Low urinary tract infection | 73 (8.9) | 3 | 70 | |||||
| Salpingitis | 1 (0.1) | 1 (0.4) | – | 1 | ||||
| Osteomyelitis | 1 (0.1) | 1 (0.4) | – | 1 | ||||
| Myositis | 1 (0.1) | 1 (0.4) | – | 1 | ||||
| Otitis | 11 (1.3) | 2 | 9 | |||||
| Sinusitis | 5 (0.6) | – | 5 | |||||
| Erysipelas | 1 (0.1) | 1 (0.4) | 1 | – | ||||
| Dermo-hypodermitis | 8 (1.0) | 2 | 6 | |||||
| Tetanus | 4 (0.5) | – | 4 | |||||
| Sepsis | 69 (8.4) | 69 (29.6) | 33 | 26 | ||||
a
Several illnesses may have occurred during one hospitalization in a given patient;
b
type of mycobacteriae non-specified;
c
infectious diarrhoea: germ not identified.